Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,555 | -5,884 | -3,347 | -16,268 | -13,087 |
| Depreciation Amortization | 19 | 13 | 6 | 25 | 19 |
| Accounts payable and accrued liabilities | 498 | 394 | 866 | -2,268 | -1,700 |
| Other Working Capital | 154 | 347 | 917 | -2,101 | -1,738 |
| Other Operating Activity | 1,052 | 685 | -431 | 5,392 | 3,954 |
| Operating Cash Flow | $-6,832 | $-4,445 | $-1,989 | $-15,220 | $-12,552 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 0 | 6,354 | 6,354 |
| Investing Cash Flow | $N/A | $N/A | $0 | $6,354 | $6,354 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,560 | 4,088 | 345 | 3,553 | 506 |
| Other Financing Activity | -1,251 | -17 | -17 | -653 | -82 |
| Financing Cash Flow | $11,309 | $4,071 | $328 | $2,900 | $424 |
| Beginning Cash Position | 2,590 | 2,590 | 2,590 | 8,556 | 8,556 |
| End Cash Position | 7,067 | 2,216 | 929 | 2,590 | 2,782 |
| Net Cash Flow | $4,477 | $-374 | $-1,661 | $-5,966 | $-5,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,832 | -4,445 | -1,989 | -15,220 | -12,552 |
| Free Cash Flow | -6,832 | -4,445 | -1,989 | -15,220 | -12,552 |